Is ARK Next Generation Internet ETF a Good Investment?
The ARK Next Generation Internet ETF looks like a pretty…
Sell
27
CRLBF Quote, Financials, Valuation and Earnings
Last price:
$0.97
Seasonality move
:
15.86%
Day range:
$0.95 - $1.02
52-week range:
$0.78 - $2.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.45x
P/B ratio:
0.74x
Volume:
664.1K
Avg. volume:
935.7K
1-year change:
-45.96%
Market cap:
$336.3M
Revenue:
$770.9M
EPS (TTM):
-$0.20
Analysts' Opinion
-
Consensus RatingCresco Labs has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Cresco Labs has an estimated upside of 158.45% from its current price of $0.97.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.97.
Fair Value
-
According to the consensus of 7 analysts, Cresco Labs has 158.45% upside to fair value with a price target of -- per share.
CRLBF vs. S&P 500
-
Over the past 5 trading days, Cresco Labs has overperformed the S&P 500 by 6.3% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cresco Labs does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cresco Labs revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Cresco Labs reported revenues of $179.8M.
Earnings Growth
-
Cresco Labs has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cresco Labs reported earnings per share of -$0.03.
Enterprise value:
610.7M
EV / Invested capital:
--
Price / LTM sales:
0.45x
EV / EBIT:
10.36x
EV / Revenue:
0.83x
PEG ratio (5yr expected):
--
EV / Free cash flow:
8.20x
Price / Operating cash flow:
4.46x
Enterprise value / EBITDA:
4.65x
Gross Profit (TTM):
$376.6M
Return On Assets:
-4.92%
Net Income Margin (TTM):
-9.15%
Return On Equity:
-16.74%
Return On Invested Capital:
-7.35%
Operating Margin:
15.94%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $860.9M | $782.2M | $736.7M | $190.6M | $179.8M | |
| Gross Profit | $429.3M | $353.9M | $376.6M | $93.6M | $93.4M | |
| Operating Income | $89.6M | $33.2M | $117M | $21.7M | $28.7M | |
| EBITDA | $137.9M | -$188M | $131.2M | -$87.6M | $43.7M | |
| Diluted EPS | -$0.20 | -$1.09 | -$0.20 | -$0.34 | -$0.03 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $257.1M | $449M | $355.2M | $303.2M | $311.9M | |
| Total Assets | $1.2B | $1.6B | $1.8B | $1.4B | $1.4B | |
| Current Liabilities | $243.7M | $209.2M | $270.6M | $260.9M | $158.6M | |
| Total Liabilities | $465M | $857.7M | $984.8M | $973.3M | $1B | |
| Total Equity | $741.6M | $712.3M | $771.4M | $425.9M | $365.4M | |
| Total Debt | $118.9M | $479.3M | $487.4M | $518.3M | $519.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $52.8M | $65.5M | $99.7M | $40.6M | $49.4M | |
| Cash From Investing | -$88.2M | -$59.6M | -$19.6M | -$12.5M | -$6.3M | |
| Cash From Financing | -$87M | -$25.2M | -$33.2M | $10.1M | -$2.5M | |
| Free Cash Flow | -$37.9M | -$524K | $74.5M | $27.3M | $43.1M | |
CRLBF
Sector
Market Cap
$336.3M
$47.1M
Price % of 52-Week High
36.5%
48%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-45.96%
-33.14%
Beta (5-Year)
1.941
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$0.93
200-day SMA
Sell
Level
$1.63
Bollinger Bands (100)
Sell
Level
1.09 - 1.71
Chaikin Money Flow
Sell
Level
-78.5M
20-day SMA
Buy
Level
$0.93
Relative Strength Index (RSI14)
Sell
Level
46.56
ADX Line
Buy
Level
32.5
Williams %R
Neutral
Level
-27.1054
50-day SMA
Sell
Level
$1.14
MACD (12, 26)
Sell
Level
-0.05
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Sell
Level
-33.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.5742)
Sell
CA Score
(Annual)
Level (-1.0441)
Buy
Beneish M-Score
(Annual)
Level (-3.4495)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.1797)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.
Stock Forecast FAQ
In the current month, CRLBF has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CRLBF average analyst price target in the past 3 months is --.
-
Where Will Cresco Labs Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cresco Labs share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Cresco Labs?
Analysts are divided on their view about Cresco Labs share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cresco Labs is a Sell and believe this share price will drop from its current level to --.
-
What Is Cresco Labs's Price Target?
The price target for Cresco Labs over the next 1-year time period is forecast to be -- according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is CRLBF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cresco Labs is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CRLBF?
You can purchase shares of Cresco Labs via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cresco Labs shares.
-
What Is The Cresco Labs Share Price Today?
Cresco Labs was last trading at $0.97 per share. This represents the most recent stock quote for Cresco Labs. Yesterday, Cresco Labs closed at $0.97 per share.
-
How To Buy Cresco Labs Stock Online?
In order to purchase Cresco Labs stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Why Is General Electric Stock Going Up?
General Electric Company, doing business these days as GE Aerospace…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
1
IONQ alert for Jan 10
IonQ [IONQ] is up 1.55% over the past day.
Sell
40
QMCO alert for Jan 10
Quantum [QMCO] is up 0.19% over the past day.
Sell
47
MATW alert for Jan 10
Matthews International [MATW] is down 2.13% over the past day.
